Osler, Hoskin & Harcourt LLP advised Wealthsimple in its financing round, while Latham & Watkins LLP, working alongside McCarthy Tétrault LLP, represented Meritech and Greylock. Wealthsimple...
Wealthsimple’s $750 Million Financing Round
Alan’s €185 Million Series D Financing
IN BRIEF: Latham & Watkins, Orrick Herrington & Sutcliffe LLP, advised on the matter. Latham & Watkins advised Coatue Management, L.L.C. with a team including Pierre-Louis...
Crossover Health’s $168 Million Series D Financing
Latham & Watkins LLP represented Crossover Health in the transaction. Crossover Health, a relationship-based, tech-enabled, national healthcare organization that integrates both virtual and in-person care for...
Enovix’s $1.128 Billion Merger with Rodgers Silicon Valley Acquisition Corp
Latham & Watkins LLP represented Eclipse Ventures in the transaction. Enovix Corporation, the leader in the design and manufacture of next generation 3D Silicon™ Lithium-ion batteries,...
Owlet Baby Care’s $1.39 Billion Merger with Sandbridge Acquisition Corporation
Latham & Watkins LLP advised Owlet Baby Care, while Ropes & Gray LLP advised Sandbridge on the deal. Owlet Baby Care Inc. and Sandbridge Acquisition Corporation...
0x Labs’ $15 Million Series A Funding Round
Latham & Watkins LLP represented Pantera Capital in the transaction. 0x Labs, the firm behind a decentralized exchange (DEX) protocol and the ZRX token, has closed...
Arya Sciences Acquisition Corp III’s Merger with Nautilus Biotechnology
Wilson Sonsini Goodrich & Rosati, P.C. advised Nautilus Biotechnology, while Kirkland & Ellis LLP, working alongside Ogier, advised Arya III on the deal. Latham & Watkins...